age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
63.93399
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 39,951
| 23,115.0156
| null | 29.666656
|
white
| 38
| 62
| 0.404968
| 0.28595
| 15
| 1
| 0
|
no
| 0.25
| 0.5
|
no dnr
| 18
| 49
| 10.798828
| 122
| 38
| 38.79688
| 174
| 2.599609
| 0.899902
| 5.199219
| 139
| 7.349609
| null | null | null | 0
| null | null | 0.4948
| 926
| 1
|
73.336
|
male
| 1
| 6
|
Lung Cancer
|
Cancer
| 2
| 8
| null | 0
| 6,528
| 4,465.707
| null | 18
|
white
| 18.199219
| 19
| 0.661987
| 0.358948
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 1
| 79
| 4.699219
| 100
| 24
| 36.79688
| 433.3125
| 3.399902
| 0.599976
| 0.799927
| 134
| 7.359375
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
57.21799
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 7
| null | 0
| 6,209
| 3,865.9766
| null | 22
|
white
| 9.699219
| 15
| 0.837891
| 0.645996
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 5
| 106
| 6.599609
| 88
| 20
| 36.79688
| null | 3.899902
| 0.899902
| 1.199951
| 141
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,875
| 0
|
64.58899
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 20,287
| 12,675.5625
| null | 17.333328
|
white
| 17.796875
| 34
| 0.883911
| 0.805908
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 8
| 75
| 6.599609
| 80
| 24
| 36.59375
| 490
| 3.599609
| 1.299805
| 1.5
| 130
| 7.459961
| null | null | null | null | null | null | 2.582031
| 61
| 1
|
73.73297
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 35,954
| 25,675.9688
| null | 27.333328
|
white
| 23.199219
| 55
| 0.787964
| 0.718994
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 18
| 105
| 9.898438
| 112
| 28
| 39.09375
| 332
| 2.399902
| null | 2
| 143
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,873
| 0
|
61.01599
|
male
| 0
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 43,814
| 19,164
| null | 36.333313
|
white
| 32.59375
| 36
| 0.317993
| 0.204987
| 7
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 16
| 48
| 4
| 118
| 34
| 38
| 372
| null | 1.5
| 1.299805
| 148
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 130
| 1
|
43.26898
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 11,032
| 4,530.9414
| null | 47
|
white
| 52.398438
| 89
| 0.243988
| 0.140991
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
no dnr
| 4
| 43
| 28
| 140
| 26
| 39
| 72
| 2.299805
| 4
| 3.799805
| 137
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.13916
| 4
| 1
|
61.63397
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 13,547
| 7,884.6055
| null | 10.5
|
white
| 24
| 39
| 0.825928
| 0.716919
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 11
| 85
| 7.199219
| 160
| 24
| 36.09375
| null | null | 2.399902
| 1.599854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,867
| 0
|
83.30194
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 3,822
| 2,581.4356
| null | 13
|
white
| 24.398438
| 36
| 0.727905
| 0.573975
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
dnr after sadm
| 1
| 71
| 10.398438
| 54
| 24
| 35.59375
| 290
| null | null | 2.399902
| 139
| 7.449219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 130
| 1
|
83.01996
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
| null | 0
| 21,266
| 11,367.5859
| null | 19
|
white
| 28.699219
| 50
| 0.619995
| 0.514893
| 2
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 20
| 53
| 17.5
| 68
| 32
| 36.5
| 156
| 2.599609
| 1.199951
| 0.599976
| 140
| 7.369141
| null | null | null | 3
| 0
|
no(M2 and SIP pres)
| 0
| 1,577
| 1
|
49.28699
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 0
| 106,935
| 81,057.125
| null | 25.75
|
black
| 35.296875
| 57
| 0.562988
| 0.450989
| 36
| 0
| 0
|
no
| 0.85
| 0.9
|
no dnr
| 31
| 75
| 17.398438
| 112
| 0
| 38.5
| 146
| null | null | 3.199707
| 149
| 7.389648
| null | null | null | null | 2
|
SIP>=30
| 2
| 1,866
| 0
|
65.46198
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 68,682
| 57,570.2188
| null | 42.666657
|
white
| 26.398438
| 47
| 0.740967
| 0.660889
| 3
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 9
| 63
| 16.5
| 75
| 20
| 38.59375
| 140
| null | 1.299805
| 5.699219
| 137
| 7.349609
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
75.63898
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
$25-$50k
| 0
| 5,284
| 3,609.7305
| null | 5
|
white
| 19.097656
| 26
| 0.839966
| 0.737915
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 7
| 105
| 5.399414
| 68
| 24
| 37
| 235
| null | null | 2.5
| 142
| 7.449219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 322
| 1
|
54.43698
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 12,503
| 7,265.9961
| null | 25
|
white
| 19.296875
| 25
| 0.894897
| 0.823975
| 1
| 1
| 0
|
no
| 0.5
| 0.125
|
no dnr
| 8
| 75
| 10
| 106
| 24
| 36.39844
| 300
| null | null | 1.399902
| 138
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,864
| 0
|
49.61499
|
female
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 42,791
| 33,042.8438
| null | 46.5
|
white
| 32.695313
| 58
| 0.352966
| 0.235992
| 5
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 8
| 55
| 23.199219
| 150
| 10
| 39.19531
| 140
| 1.899902
| null | 0.5
| 146
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.501953
| 11
| 1
|
40.68698
|
female
| 1
| 18
|
Lung Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 26,951
| 17,289.8281
| null | 15.666664
|
asian
| 21.597656
| 22
| 0.671997
| 0.373962
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 5
| 83
| 5.799805
| 80
| 28
| 36.29688
| null | 2.799805
| 1.899902
| 1.699951
| 136
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
41.448
|
male
| 0
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 15,982
| 8,234.9922
| null | 13.5
|
white
| 24.296875
| 42
| 0.826904
| 0.716919
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 13
| 57
| 9.5
| 60
| 40
| 36.19531
| null | 2.099609
| 2.699707
| 0.599976
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,861
| 0
|
75.34296
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 5,532
| 3,669.9375
| null | 9
|
black
| 17.097656
| 27
| 0.862915
| 0.772949
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 100
| 6.699219
| 60
| 20
| 37
| 242.84375
| null | 0.799927
| 1.699951
| 139
| 7.429688
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,859
| 0
|
69.35797
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 4,764
| 3,248.6406
| null | 10
|
white
| 14.199219
| 25
| 0.899902
| 0.831909
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 6
| 98
| 8.298828
| 80
| 24
| 37
| 259.25
| null | null | 1.399902
| 140
| 7.469727
| null | null | null | 5
| 4
|
SIP>=30
| 4
| 1,471
| 1
|
54.43399
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 4,818
| 3,069.916
| null | 12
|
black
| 22.296875
| 16
| 0.618896
| 0.304993
| 1
| 0
| 0
|
metastatic
| null | null |
dnr before sadm
| -1
| 100
| 13.398438
| 120
| 20
| 37.79688
| null | 3.199707
| 0.599976
| 0.899902
| 142
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.205566
| 11
| 1
|
75.07996
|
female
| 0
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 5
|
under $11k
| 0
| 39,957
| 32,404.2969
| null | 40.333313
|
white
| 20.699219
| 24
| 0.804932
| 0.68396
| 1
| 0
| 0
|
no
| 0.19
| 0.19
|
dnr after sadm
| 6
| 117
| 11.5
| 64
| 6
| 38.39844
| 206.65625
| 3
| null | 1.599854
| 142
| 7.349609
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 52
| 1
|
54.66397
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 96,588
| 50,266.9688
| null | 43
|
white
| 54.398438
| 87
| 0.051994
| 0.016998
| 23
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 8
| 57
| 3.099609
| 140
| 26
| 35.79688
| 160
| 3
| 33
| 3.699707
| 132
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 1.996094
| 8
| 1
|
72.40497
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 0
| 48,378
| 31,511.7344
| null | 28.5
|
white
| 21.199219
| 33
| 0.777954
| 0.705933
| 7
| 1
| 0
|
no
| 0.93
| 0.9
|
no dnr
| 10
| 69
| 12.699219
| 110
| 28
| 39
| 220
| null | null | 0.899902
| 143
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,855
| 0
|
75.12695
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 9
| null | 0
| 53,401
| 33,741.6562
| null | 14.333328
|
white
| 20.5
| 33
| 0.806885
| 0.687988
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
no dnr
| 16
| 87
| 6.699219
| 70
| 26
| 35.19531
| 217.375
| null | 0.399963
| 1.5
| 144
| 7.329102
| null | null | null | 5
| 7
|
SIP>=30
| 7
| 1,013
| 1
|
65.05096
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 16
|
$25-$50k
| 0
| 6,174
| 4,199.1641
| null | 5
|
white
| 14.798828
| 9
| 0.748901
| 0.487976
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 8
| 85
| 4.799805
| 72
| 18
| 36.29688
| null | 3.599609
| 0.799927
| 0.799927
| 147
| null | null | null | null | 4
| 0
|
SIP>=30
| 0
| 177
| 1
|
62.35498
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 20
| null | 9
| 45,424
| 36,292.4062
| null | 29.75
|
white
| 35.898438
| 55
| 0.543945
| 0.429993
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 26
| 55
| 2.199707
| 105
| 28
| 38.69531
| 179.5625
| 3.299805
| 0.699951
| 2.299805
| 132
| 7.469727
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 28
| 1
|
51.767
|
female
| 1
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 6,608
| 4,792.4727
| null | 11.5
|
white
| 40.59375
| 38
| 0.305969
| 0.052994
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 1
| 70
| 15.199219
| 128
| 22
| 36.59375
| null | 2.5
| 12.298828
| 0.699951
| 137
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
72.64099
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
>$50k
| 0
| 30,733
| 16,213.8359
| null | 16
|
white
| 26.898438
| 42
| 0.688965
| 0.596924
| 4
| 1
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 22
| 74
| 12.798828
| 76
| 24
| 36.09375
| 217.5
| 2
| 1.699951
| 3.899902
| 131
| 7.339844
| null | null | null | 0
| 1
| null | 1
| 1,489
| 1
|
87.70996
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 100
| 46,354
| 16,436.5938
| null | 31.75
|
white
| 33.296875
| 47
| 0.051994
| 0.015999
| 1
| 0
| 1
|
no
| 0.5
| 0.25
|
no dnr
| 27
| 61
| 17.597656
| 107
| 28
| 36.19531
| 124.48438
| 3.399902
| 0.799927
| 2.5
| 136
| 7.299805
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,848
| 0
|
80.159
|
male
| 0
| 82
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$25-$50k
| 0
| 131,511
| 100,763.688
| null | 29
|
white
| 26.796875
| 46
| 0.608887
| 0.50293
| 14
| 1
| 0
|
no
| 0.95
| 0.9
|
dnr after sadm
| 30
| 80
| 18
| 80
| 32
| 38.09375
| 98
| null | null | 1.899902
| 141
| 7.399414
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,199
| 1
|
57.51999
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 6,630
| 4,241.5977
| null | 15
|
white
| 11.798828
| 12
| 0.810913
| 0.593994
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 6
| 83
| 6.899414
| 104
| 24
| 36.69531
| null | 3.899902
| 0.5
| 1.099854
| 142
| null | null | null | null | 0
| 3
|
no(M2 and SIP pres)
| 3
| 106
| 1
|
74.51599
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| 14
|
under $11k
| 9
| 3,122
| 2,082.5606
| null | 14
|
white
| 19.296875
| 37
| 0.594971
| 0.27594
| 1
| 0
| 0
|
metastatic
| 0.5
| 0
|
dnr after sadm
| 1
| 100
| 7.899414
| 60
| 5
| 36.09375
| null | 3.699707
| 0.699951
| 1.299805
| 147
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 4
| 1
|
67.034
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 25,793
| 11,789.1562
| null | 17
|
white
| 19.5
| 29
| 0.860962
| 0.769897
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 13
| 70
| 13.298828
| 54
| 26
| 36.69531
| 240
| 3.399902
| 0.599976
| 1.199951
| 137
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 245
| 1
|
65.53894
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 19
|
>$50k
| 0
| 10,474
| 6,287.6641
| null | 14
|
white
| 16
| 21
| 0.896973
| 0.826904
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 10
| 85
| 5.599609
| 92
| 22
| 37.19531
| 385.6875
| null | null | 1.5
| 136
| 7.5
| null | null | null | 0
| 0
| null | 0
| 1,846
| 0
|
76.44397
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,718
| 3,549.4473
| null | 15
|
white
| 27
| 37
| 0.713989
| 0.554932
| 1
| 1
| 0
|
no
| 0.91
| 0.91
|
no dnr
| 7
| 117
| 8.099609
| 70
| 20
| 36.09375
| 211.09375
| 2.799805
| null | 3.5
| 141
| 7.419922
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 181
| 1
|
75.27698
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,045
| 3,920.6856
| null | 17
|
white
| 19.699219
| 36
| 0.833984
| 0.727905
| 1
| 0
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 7
| 65
| 11.398438
| 64
| 22
| 37.59375
| 197.5
| null | null | 1.699951
| 145
| 7.479492
| null | null | null | 3
| 0
|
<2 mo. follow-up
| 0
| 30
| 1
|
84.41595
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 4
| null | 0
| 11,238
| 8,764.9141
| null | 21
|
white
| 22.597656
| 41
| 0.68396
| 0.514893
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 57
| 8.199219
| 61
| 34
| 37.59375
| 197.5
| 3
| 0.899902
| 1.699951
| 135
| 7.40918
| null | null | null | 0
| 3
|
no(M2 and SIP pres)
| 3
| 1,843
| 0
|
82.09399
|
male
| 1
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 13,125
| 9,268.6562
| null | 32
|
white
| 31.597656
| 59
| 0.360962
| 0.168976
| 4
| 0
| 1
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 2
| 68
| 13.398438
| 85
| 40
| 37.19531
| 185.6875
| 2.399902
| 0.699951
| 2
| 132
| 7.529297
| null | null | null | null | null |
<2 mo. follow-up
| 5.226563
| 4
| 1
|
78.25598
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| null | null | 0
| 7,774
| 2,277.2676
| null | 12
|
white
| 25.296875
| 43
| 0.498962
| 0.427979
| 3
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 4
| 67
| null | 128
| 4
| 41.09375
| null | null | null | null | 140
| null | null | null | null | null | null |
<2 mo. follow-up
| 1.734863
| 4
| 1
|
81.56299
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 15,296
| 8,135.9922
| null | 13.666664
|
white
| 21.898438
| 29
| 0.763916
| 0.688965
| 2
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 14
| 54
| 7.5
| 59
| 24
| 38.69531
| 330
| null | null | 0.799927
| 129
| 7.439453
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,842
| 0
|
61.306
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 74,086
| 60,316.625
| null | 29.5
|
white
| 41.5
| 56
| 0.348999
| 0.232971
| 7
| 0
| 0
|
no
| 0.02
| 0.000008
|
dnr after sadm
| 1
| 41
| 34.398438
| 210
| 24
| 38.39844
| 96.25
| 3
| null | 1.399902
| 144
| 7.30957
| null | null | null | null | null | null | 2.189941
| 830
| 1
|
70.68896
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 49,259
| 22,383.4375
| null | 42
|
white
| 40.898438
| 52
| 0.389954
| 0.270996
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 14
| 46
| 14
| 126
| 10
| 36.59375
| 153.03125
| 2.799805
| 0.599976
| 4.5
| 140
| 7.229492
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 17
| 1
|
89.31396
|
male
| 1
| 28
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 26,630
| 16,067.7109
| null | 11.5
|
white
| 22.5
| 47
| 0.602905
| 0.412964
| 2
| 0
| 1
|
no
| 0.6
| 0.3
|
dnr before sadm
| -1
| 123
| 10.898438
| 62
| 28
| 38.09375
| 286.625
| 3.099609
| null | 1.799805
| 148
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
63.58099
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 5,187
| 3,958.7441
| null | 10
|
white
| 30.796875
| 30
| 0.543945
| 0.221985
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.4
|
dnr after sadm
| 3
| 93
| 12.798828
| 98
| 24
| 36.59375
| null | 2.5
| 10.398438
| 1
| 133
| null | null | null | null | 4
| null |
no(M2 and SIP pres)
| 3.183199
| 1,839
| 0
|
92.29797
|
female
| 0
| 29
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 9
| 19,765
| 14,352.9297
| null | 8.25
|
white
| 22.699219
| 38
| 0.678955
| 0.509888
| 1
| 0
| 0
|
no
| 0.8
| 0.55
|
dnr after sadm
| 1
| 97
| 15.298828
| 80
| 24
| 36.19531
| 233.3125
| 3.299805
| 1
| 2.399902
| 144
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 3.900879
| 41
| 1
|
74.409
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 26,899
| 17,381.4844
| null | 32.5
|
white
| 23.898438
| 25
| 0.759888
| 0.68396
| 2
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 2
| 47
| 12.099609
| 67
| 20
| 38.89844
| 320
| null | null | 1.099854
| 137
| 7.379883
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 69
| 1
|
88.172
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 6,992
| 2,529.5703
| null | 34
|
white
| 78.1875
| 73
| 0
| 0
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 0
| 10.699219
| 0
| 30
| 36.39844
| 312.5
| null | 1.299805
| 5.599609
| 126
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 1.862549
| 3
| 1
|
82.32697
|
male
| 1
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 15,828
| 5,706.2148
| null | 46
|
white
| 39
| 58
| 0.287964
| 0.113998
| 1
| 1
| 1
|
no
| 0
| 0
|
dnr after sadm
| 5
| 42
| 17.398438
| 104
| 32
| 36.39844
| 218
| null | 1.599854
| 2.699707
| 145
| 7.329102
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 6
| 1
|
95.41394
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 0
| 21,600
| 8,630.2812
| null | 23
|
white
| 27.5
| 58
| 0.599976
| 0.492981
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 16
| 57
| 8.199219
| 77
| 40
| 38.89844
| 90
| null | 0.699951
| 1.599854
| 148
| 7.069336
| null | null | null | 4
| 4
|
adl>=4 (>=5 if sur)
| 4
| 944
| 1
|
76.12598
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 4,546
| 2,898.5039
| null | 11
|
white
| 15.398438
| 33
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 107
| 3.299805
| 80
| 21
| 37.19531
| 230
| null | null | 1.099854
| 131
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,826
| 0
|
86.49097
|
male
| 0
| 114
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 19
|
under $11k
| 9
| 110,134
| 74,480.9375
| null | 9.25
|
white
| 24
| 34
| 0.690918
| 0.598999
| 1
| 0
| 1
|
no
| 0.75
| 0.75
|
no dnr
| 114
| 131
| 8.599609
| 78
| 28
| 36.69531
| 85
| 2.599609
| 0.599976
| 0.699951
| 140
| 7.529297
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 294
| 1
|
70.21796
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 27,165
| 17,051.6719
| null | 10
|
white
| 33
| 44
| 0.610962
| 0.505981
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 9
| 80
| 3
| 100
| 26
| 35
| 404.75
| 2.199707
| 1.899902
| 8.199219
| 135
| 7.539062
| null | null | null | 3
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
69.84796
|
female
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 9
| 27,437
| 11,603.9375
| null | 21.666656
|
hispanic
| 20.898438
| 19
| 0.764893
| 0.626953
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
dnr after sadm
| 3
| 50
| 15
| 63
| 10
| 38
| 225
| 3.799805
| 0.199982
| 0.599976
| 137
| 7.379883
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 126
| 1
|
48.909
|
male
| 0
| 111
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 162,243
| 92,695.5
| null | 42
|
white
| 42.796875
| 53
| 0.587891
| 0.395996
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 111
| 47
| 18.296875
| 121
| 10
| 33.29688
| 249
| 2.599609
| 1.399902
| 1.199951
| 138
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 410
| 1
|
70.65295
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 3
| 5
|
$25-$50k
| 0
| 8,013
| 4,871.3359
| null | 2.5
|
white
| 15.5
| 25
| 0.826904
| 0.623901
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 8
| 77
| 8.699219
| 60
| 28
| 37.89844
| null | null | null | 1
| 143
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 231
| 1
|
39.12698
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 9
| 19,532
| 14,328.2969
| null | 16.666656
|
white
| 22
| 31
| 0.882935
| 0.840942
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 18
| 68
| 17.398438
| 144
| 28
| 38.39844
| 424
| null | null | 1.199951
| 136
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,823
| 0
|
69.21295
|
female
| 1
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 19,470
| 5,971.9727
| null | 29.5
|
white
| 31.398438
| 71
| 0.652954
| 0.475952
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 9
| 53
| 21.898438
| 165
| 38
| 36.89844
| 203.6875
| 4.099609
| null | 2.399902
| 134
| 7.399414
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
19.75099
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
under $11k
| 0
| 8,945
| 3,473.5801
| null | 21
|
black
| 20
| 13
| 0.932983
| 0.907959
| 2
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 6
| 113
| 14.599609
| 112
| 24
| 37.09375
| 245
| null | null | 0.899902
| 137
| 7.389648
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.625244
| 1,822
| 0
|
65.87799
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 10,435
| 3,580.7969
| null | 33
|
white
| 35.796875
| 59
| 0.565918
| 0.453979
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 47
| 15.099609
| 110
| 22
| 39.19531
| 150
| 2
| 2.5
| 1.599854
| 145
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 2.192383
| 4
| 1
|
85.89996
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 9,867
| 6,423.6914
| null | 12
|
white
| 16.796875
| 31
| 0.835938
| 0.780884
| 1
| 0
| 1
|
no
| 0.5
| 0.1
|
dnr after sadm
| 2
| 57
| 8.699219
| 64
| 20
| 37.39844
| null | 2.699707
| 1.799805
| 0.799927
| 142
| null | null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 358
| 1
|
77.73895
|
male
| 1
| 121
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
|
$25-$50k
| 0
| 298,360
| 198,960.125
| null | 13.5
|
white
| 28.699219
| 44
| 0.668945
| 0.572998
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
dnr after sadm
| 120
| 132
| 10.398438
| 115
| 8
| 38.19531
| 141.65625
| 3.599609
| null | 2.599609
| 138
| 7.369141
| null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 121
| 1
|
88.03595
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 0
| 15,815
| 12,376.2344
| null | 12.333328
|
white
| 19.097656
| 36
| 0.79895
| 0.73291
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 71
| 5.5
| 76
| 45
| 38.5
| 388
| null | 0.5
| 1.699951
| 137
| 7.40918
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,820
| 0
|
71.66595
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
>$50k
| 0
| 7,804
| 6,189.3398
| null | 20
|
white
| 13.298828
| 20
| 0.898926
| 0.830933
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 7
| 71
| 7.299805
| 74
| 20
| 36.29688
| 542.75
| 3.799805
| null | 1.299805
| 137
| 7.389648
| null | null | null | 0
| 0
| null | 0
| 126
| 1
|
70.31897
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,416
| 2,761.2207
| null | 17
|
white
| 15
| 12
| 0.733887
| 0.463989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 60
| 5.199219
| 80
| 20
| 37.79688
| null | null | 1.099854
| 0.599976
| 135
| null | null | null | null | null | null |
<2 mo. follow-up
| 1.990967
| 19
| 1
|
69.14398
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 10,137
| 5,123.7227
| null | 12.5
|
white
| 13.298828
| 16
| 0.906982
| 0.843994
| 1
| 0
| 0
|
no
| 0.95
| 0.65
|
no dnr
| 9
| 83
| 6.5
| 76
| 32
| 36.19531
| 337
| 4
| 0.5
| 0.799927
| 137
| 7.389648
| null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 58
| 1
|
80.87097
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 10,512
| 4,263.2422
| null | 16.5
|
white
| 25.597656
| 49
| 0.672974
| 0.501953
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 77
| 17.296875
| 134
| 28
| 36.5
| 190.46875
| null | null | 0.899902
| 136
| 7.339844
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,174
| 1
|
72.67596
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 11,472
| 7,616.8633
| null | 19
|
white
| 22.898438
| 36
| 0.771973
| 0.698975
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 7
| 67
| 10.599609
| 62
| 26
| 36.09375
| 471.625
| 2.899902
| 1
| 1.799805
| 134
| 7.509766
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 45
| 1
|
90.11597
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 5
|
under $11k
| 0
| 10,945
| 6,067.9414
| null | 9.5
|
white
| 15
| 28
| 0.793945
| 0.667969
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
dnr after sadm
| 1
| 93
| 5.399414
| 82
| 28
| 37
| 285.6875
| null | null | 1.099854
| 144
| 7.269531
| null | null | null | 5
| null |
<2 mo. follow-up
| 3.855299
| 27
| 1
|
91.88995
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null |
>$50k
| 0
| 5,870
| 3,882.2109
| null | 17
|
white
| 12.398438
| 35
| 0.863892
| 0.775879
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 1
| 75
| 8.699219
| 60
| 24
| 36.69531
| 400
| 4.599609
| null | 1.899902
| 135
| 7.259766
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,813
| 0
|
85.29498
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
under $11k
| 26
| 22,704
| 10,671.1172
| null | 39
|
black
| 29.699219
| 41
| 0.376953
| 0.258972
| 10
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 63
| 19.199219
| 138
| 46
| 39.29688
| 173.3125
| 3.199707
| 1.199951
| 0.799927
| 132
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
78.06195
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 6
| null | 0
| 12,894
| 8,858.2969
| null | 9.666664
|
white
| 21.699219
| 35
| 0.795898
| 0.670898
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 16
| 65
| 5.199219
| 98
| 32
| 36.19531
| null | 3.299805
| 0.5
| 1.599854
| 134
| null | null | null | null | 0
| 5
|
<2 mo. follow-up
| 5
| 36
| 1
|
77.36896
|
male
| 1
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
$11-$25k
| 9
| 159,774
| 82,870.6875
| null | 36.75
|
white
| 37.296875
| 45
| 0.284973
| 0.175995
| 15
| 0
| 0
|
no
| 0.95
| 0.8
|
dnr after sadm
| 68
| 43
| 5.699219
| 189
| 16
| 36.59375
| 153.03125
| 2.299805
| null | 0.799927
| 136
| 7.399414
| null | null | null | 4
| 3
|
no(M2 and SIP pres)
| 3
| 75
| 1
|
57.47598
|
female
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 27,525
| 15,043.7344
| null | 25.333328
|
hispanic
| 22.097656
| 30
| 0.61792
| 0.512939
| 7
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 17
| 111
| 6.199219
| 110
| 26
| 36.79688
| 250
| null | null | 1.299805
| 149
| 7.519531
| null | null | null | 0
| null |
adl>=4 (>=5 if sur)
| 0.4948
| 59
| 1
|
75.12097
|
female
| 0
| 121
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 0
| 171,895
| 117,669.438
| null | 27.75
|
white
| 31.597656
| 66
| 0.616943
| 0.511963
| 1
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 121
| 53
| 15.599609
| 160
| 8
| 36.39844
| 248
| 3.399902
| 1.799805
| 2
| 146
| 7.209961
| null | null | null | null | 5
|
SIP>=30
| 5
| 1,809
| 0
|
36.16397
|
male
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 90,237
| 73,488.125
| null | 40.25
|
white
| 20.296875
| 22
| 0.901978
| 0.866943
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 44
| 127
| 11
| 102
| 14
| 38.5
| 191.65625
| null | null | 0.899902
| 134
| 7.449219
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,810
| 0
|
76.10999
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 0
| null | 37
| 21,743
| 18,019.5156
| null | 35
|
white
| 25.199219
| 36
| 0.582886
| 0.472961
| 2
| 0
| 1
|
no
| 0.75
| 0.25
|
no dnr
| 11
| 113
| 12.798828
| 70
| 28
| 38.79688
| 103
| null | null | 1.399902
| 143
| 7.489258
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 5.44043
| 833
| 1
|
87.13995
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 19,842
| 5,105.0781
| null | 34
|
white
| 32
| 46
| 0.449951
| 0.329956
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 4
| 43
| 7.099609
| 114
| 12
| 38.19531
| 285
| 4
| 1.199951
| 2.099609
| 143
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 3.121582
| 12
| 1
|
76.80194
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 32,927
| 20,705.5312
| null | 27
|
white
| 22
| 33
| 0.72998
| 0.576904
| 5
| 1
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 13
| 72
| 16.097656
| 102
| 28
| 38.09375
| 177.53125
| null | null | 1.399902
| 138
| 7.509766
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 713
| 1
|
85.62097
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 13,883
| 8,324.8047
| null | 7.666664
|
white
| 26.898438
| 46
| 0.662964
| 0.487976
| 1
| 0
| 0
|
no
| 0.98
| 1
|
no dnr
| 17
| 53
| 5.699219
| 69
| 30
| 38
| 126.51562
| null | 0.599976
| 1.699951
| 136
| 7.369141
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 1,057
| 1
|
82.83099
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 7,412
| 3,651.3867
| null | 15
|
white
| 19.796875
| 45
| 0.766968
| 0.628906
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
dnr after sadm
| 2
| 65
| null | 71
| 35
| 36.89844
| 220
| 3.799805
| 0.5
| 3
| 140
| 7.379883
| null | null | null | 6
| null |
adl>=4 (>=5 if sur)
| 4.527397
| 139
| 1
|
67.26099
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 9,286
| 5,743.0938
| null | 8.5
|
black
| 15.599609
| 20
| 0.895996
| 0.824951
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 8
| 113
| 6.899414
| 90
| 24
| 37.79688
| 421.625
| 3.299805
| 0.299988
| 1.5
| 144
| 7.379883
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 49
| 1
|
78.07794
|
female
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$25-$50k
| 0
| 13,959
| 9,974.7891
| null | 8
|
white
| 15.898438
| 32
| 0.848999
| 0.751953
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 1
| 67
| 4.699219
| 80
| 20
| 36.69531
| 220
| null | null | 0.799927
| 133
| 7.5
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 355
| 1
|
48.05698
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 19
|
>$50k
| 0
| 9,250
| 2,868.1894
| null | 30
|
white
| 49.5
| 56
| 0.036995
| 0.009998
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 3
| 49
| 1.5
| 124
| 44
| 34.59375
| 145
| 2.799805
| 0.599976
| 0.699951
| 130
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
70.75195
|
female
| 0
| 20
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 19,308
| 13,598.2031
| null | 7.666664
|
white
| 15.898438
| 15
| 0.716919
| 0.438965
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 20
| 103
| 12.898438
| 76
| 16
| 36.69531
| null | 3.399902
| 0.5
| 0.899902
| 141
| null | null | null | null | null | null | null | 2.953125
| 179
| 1
|
85.06494
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 15,635
| 7,769.6562
| null | 18
|
white
| 22.597656
| 35
| 0.754883
| 0.67688
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 13
| 50
| 11.898438
| 85
| 20
| 37.89844
| 235
| 3.599609
| 0.5
| 0.799927
| 133
| 7.319336
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 82
| 1
|
43.21399
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 21
|
>$50k
| 0
| 22,535
| 9,573.2734
| null | 22.5
|
white
| 30.296875
| 62
| 0.720947
| 0.564941
| 1
| 0
| 0
|
no
| 0.6
| 0.33
|
no dnr
| 10
| 58
| 11.298828
| 132
| 56
| 38.89844
| 261.875
| 2.399902
| 2.599609
| 0.399963
| 145
| 7.509766
| null | null | null | null | 3
| null | 3
| 322
| 1
|
61.862
|
female
| 0
| 96
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 139,856
| 89,639.3125
| null | 35
|
black
| 30
| 62
| 0.730957
| 0.578979
| 1
| 1
| 0
|
no
| 0.7
| 0.65
|
dnr after sadm
| 6
| 53
| 11.898438
| 69
| 32
| 38.69531
| 316
| 2.799805
| null | 6.699219
| 137
| 7.229492
| null | null | null | null | 2
|
SIP>=30
| 2
| 1,362
| 1
|
55.64099
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 14
| null | 0
| 12,424
| 7,868.0664
| null | 22
|
white
| 13.898438
| 17
| 0.781982
| 0.543945
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
no dnr
| 11
| 103
| 7
| 88
| 16
| 37.79688
| null | null | 0.399963
| 1.199951
| 133
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
57.35199
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 9
| 5,977
| 3,633.5742
| null | 11
|
white
| 19.296875
| 53
| 0.643921
| 0.335999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 5
| 70
| 0.799927
| 100
| 26
| 38.79688
| 328.5625
| null | null | 1.5
| 133
| 7.479492
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.203613
| 118
| 1
|
55.66098
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 30,821
| 22,212.0469
| null | 33
|
white
| 33.09375
| 31
| 0.640991
| 0.539917
| 4
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 12
| 53
| 13.599609
| 109
| 32
| 39.09375
| 118.32812
| null | null | 0.799927
| 134
| 7.419922
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
27.228
|
male
| 0
| 100
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 95,692
| 65,816.625
| null | 14.75
|
white
| 20.699219
| 16
| 0.917969
| 0.888916
| 2
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 100
| 106
| 13.898438
| 135
| 22
| 37.89844
| 236.65625
| null | null | 1.099854
| 145
| 7.439453
| null | null | null | null | null | null | 2.666504
| 1,790
| 0
|
64.76898
|
female
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 44
| 67,778
| 34,829.25
| null | 26.75
|
white
| 23.199219
| 60
| 0.68689
| 0.593994
| 1
| 1
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 44
| 59
| 16.199219
| 67
| 32
| 38.09375
| 185.6875
| 2.799805
| 0.399963
| 8.898438
| 144
| 7.459961
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,790
| 0
|
89.05695
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 20
|
under $11k
| 89
| 21,707
| 9,177.0938
| null | 20
|
white
| 20.699219
| 41
| 0.330994
| 0.215973
| 4
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 59
| 8.5
| 115
| 36
| 38.39844
| 235
| 3.799805
| null | 1.199951
| 150
| 7.419922
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 11
| 1
|
75.625
|
male
| 0
| 35
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 33,324
| 21,974.6406
| null | 7.75
|
black
| 15.798828
| 21
| 0.861938
| 0.771973
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 16
| 72
| 8.599609
| 73
| 16
| 36
| 237.125
| 3.199707
| 0.399963
| 1
| 135
| 7.399414
| null | null | null | 7
| null | null | 5.199497
| 300
| 1
|
51.56998
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$25-$50k
| 0
| 7,933
| 5,171.043
| null | 10
|
white
| 20.5
| 18
| 0.908936
| 0.846924
| 1
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 8
| 73
| 12.699219
| 110
| 25
| 38.29688
| 329.625
| null | 0.699951
| 0.699951
| 146
| 7.399414
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,286
| 1
|
76.18896
|
female
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 58,865
| 32,778.4062
| null | 19.5
|
white
| 19
| 21
| 0.837891
| 0.782959
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 5
| 57
| 10.199219
| 63
| 6
| 38.19531
| 294.25
| 3.799805
| 0.399963
| 0.699951
| 132
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 283
| 1
|
64.66498
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 3
| 15
|
under $11k
| 0
| 3,253
| 2,141.6816
| null | 11
|
white
| 15.798828
| 22
| 0.731934
| 0.460999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 4
| 117
| 6.5
| 72
| 28
| 36.39844
| null | null | null | 1.099854
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,783
| 0
|
89.62598
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 6,769
| 4,204.9414
| null | 9
|
white
| 21.898438
| 51
| 0.671997
| 0.5
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 6
| 93
| 15.398438
| 80
| 40
| 36.09375
| 220
| 3.399902
| 0.5
| 1.699951
| 139
| 7.469727
| null | null | null | 2
| 5
|
SIP>=30
| 5
| 1,781
| 0
|
71.77295
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 6,365
| 4,270.9492
| null | 13
|
white
| 25.597656
| 29
| 0.644897
| 0.336975
| 1
| 1
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 103
| 2.399902
| 76
| 20
| 37.79688
| null | 2.199707
| 0.5
| 0.899902
| 142
| null | null | null | null | 3
| 5
|
<2 mo. follow-up
| 5
| 28
| 1
|
77.72998
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 2,752
| 1,723.9951
| null | 16
|
white
| 16.597656
| 20
| 0.842896
| 0.74292
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 3
| 120
| 7.599609
| 60
| 24
| 36.19531
| 380
| null | null | 1.099854
| 144
| 7.469727
| null | null | null | null | null | null | 2.211426
| 1,780
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.